NEW YORK, Feb. 08, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) between November 2, 2023 and October 30, 2024, both dates inclusive (the “Class Period”), of the important March 10, 2025 lead plaintiff deadline. SO WHAT: If you purchased Regeneron securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency f ...

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Nextracker Inc. common stock during the specified Class Period of the upcoming lead plaintiff deadline for a class action lawsuit [1][2]. Group 1: Class Action Details - Investors who bought Nextracker common stock between February 1, 2024, and August 1, 2024, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by February 25, 2025 [3]. - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [4]. Group 2: Allegations Against Nextracker - The lawsuit alleges that Nextracker made false and misleading statements regarding the impact of project delays on its business and financial results [5]. - Specific claims include that permitting and interconnection delays severely impaired Nextracker's ability to convert backlog into revenue, and that the company could not offset negative impacts from these delays as previously claimed [5]. - The lawsuit asserts that Nextracker lacked the competitive advantages it claimed, leading to a lack of reasonable basis for its positive statements about its business prospects [5].

NEW YORK, Feb. 05, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of ESSA Pharma Inc. (NASDAQ: EPIX) between December 12, 2023 and October 31, 2024, inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than March 25, 2025. SO WHAT: If you purchased ESSA Pharma Inc. securities during the Class ...

NEW YORK, Feb. 02, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Grocery Outlet Holding Corp. (NASDAQ: GO) between November 7, 2023 and May 7, 2024, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than March 31, 2025. SO WHAT: If you purchased Grocery Outlet securities dur ...

NEW YORK, Feb. 01, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action on behalf of purchasers of securities of Novo Nordisk A/S (NYSE: NVO) between November 2, 2022 and December 19, 2024, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than March 25, 2025. SO WHAT: If you purchased Novo Nordisk securities during the Class Per ...

CS Disco (LAW) shares soared 9.3% in the last trading session to close at $5.43. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 0.2% loss over the past four weeks.CS Disco is benefiting from strong customer engagement, strategic leadership hires, and enhanced product offerings, particularly in eDiscovery and AI capabilities.This legal technology company is expected to post quarterly loss of $0.11 per share in its upcoming report ...

NEW YORK, Jan. 28, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of Crocs, Inc. (NASDAQ: CROX) between November 3, 2022 and October 28, 2024, inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than March 24, 2025. SO WHAT: If you purchased Crocs common stock during the Class Period you m ...

NEW YORK, Jan. 25, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities, including call options, of Five9, Inc. (NASDAQ: FIVN) between June 4, 2024 and August 8, 2024, both dates inclusive (the “Class Period”), of the important February 3, 2025 lead plaintiff deadline. SO WHAT: If you purchased Five9 securities or call options during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a ...

Case Overview - Rosen Law Firm reminds purchasers of MGP Ingredients, Inc (MGPI) common stock between May 4, 2023 and October 30, 2024 of the February 14, 2025 lead plaintiff deadline [1] - Purchasers during the Class Period may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement [1] Legal Action Details - A class action lawsuit has been filed against MGPI [2] - Investors must move the Court no later than February 14, 2025 to serve as lead plaintiff [2] - Lead plaintiff is a representative party acting on behalf of other class members in directing the litigation [2] Rosen Law Firm Credentials - Rosen Law Firm represents investors globally, specializing in securities class actions and shareholder derivative litigation [3] - Achieved the largest ever securities class action settlement against a Chinese Company [3] - Ranked No 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017 [3] - Recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [3] Allegations Against MGPI - Defendants made materially false and/or misleading statements during the Class Period [4] - Failed to disclose material adverse facts about MGPI's business, operations, and prospects [4] - Touted strong demand and "normal" inventory levels in brown goods (American whiskies and tequila) despite slowdown in consumption and oversupply [4] - Assured investors they were positioned differently than competitors and had taken steps to mitigate risk, which was not true [4] Investor Options - Investors can join the MGPI class action by visiting the provided website or contacting Phillip Kim, Esq [5] - No class has been certified yet, investors are not represented by counsel unless they retain one [6] - Investors may select counsel of their choice or remain an absent class member [6] - Ability to share in any potential future recovery is not dependent upon serving as lead plaintiff [6]

NEW YORK, Jan. 24, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Joint Stock Company Kaspi.kz (NASDAQ: KSPI) between January 19, 2024 and September 19, 2024, both dates inclusive (the “Class Period”), of the important February 18, 2025 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased Kaspi.kz securities during the Class Period you may be entitled to compensation without payment of ...